YWYi Wu

Yi Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yi Wu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lactobacillus johnsonii-derived extracellular vesicles modulate gut microbiota metabolites and macrophage-related immune responses against Salmonella Typhimurium infection

    by Yi Wu, Keyuan Chen, Ting Hu, Yaoyao Luo, Yue Zhang, Guiyan Yang, Jiufeng Wang, Yaohong Zhu

    Salmonella Typhimurium is a significant pathogen causing diarrhea in weaned piglets, capable of triggering systemic inflammation and severe intestinal damage. As bioactive components of gut microbiota, extracellular vesicles (EVs) derived from Lactobacillus johnsonii (Lj-EVs) are likely to penetrate the intestinal mucus layer and reach host cells, potentially mediating host-microbiome interactions. Here, we found that Lj-EVs improved the intestinal barrier and attenuated intestinal injury in mice infected with S. Typhimurium. Multi-omics analysis showed that Lj-EVs intervention enriched mucin-utilizing Akkermansia . Moreover, Lj-EVs were associated with metabolic alterations, characterized by enhanced oxidative phosphorylation during homeostasis and suppression of HIF-1α-mediated glycolysis during infection. Proteomic profiling showed that Lj-EVs enriched functional proteins related to oxidative phosphorylation, indicating their potential immunomodulatory role. Notably, Lj-EVs modulated macrophage-mediated immune responses, contributing to limiting bacterial dissemination and alleviating intestinal inflammation. In conclusion, our study demonstrates that Lj-EVs alleviate Salmonella infection by reducing bacterial burden and confer metabolic and immunomodulatory benefits. These findings provide new evidence for future investigation of the protective roles of probiotic vesicles.


  • Salmonella enterica serovar typhimurium effectors spiA and spiC promote replication by modulating iron metabolism and oxidative stress

    by Keyuan Chen, Jing Wang, Ting Hu, Yiqing Zhao, Yi Wu, Xue Wang, Wei Li, Guiyan Yang, Linlin Zhang, Jiufeng Wang, et al.


  • Open Access

    Protective Effects of Water Extract of Fructus Ligustri Lucidi against Oxidative Stress-Related Osteoporosis In Vivo and In Vitro

    by Yi Wu, Yusheng Hu, Zeguang Zhao, Lina Xu, Ye Chen, Tongtong Liu, Qin Li

    Fructus Ligustri Lucidi (FLL) is the fruit of Ligustrum lucidum Ait and is a component of many kidney-tonifying traditional Chinese medicine formulae for treating osteoporosis. Accumulating evidence has linked oxidative stress with the progression of bone diseases. The present study aimed to identify the effects of FLL on oxidative stress-related osteoporosis in vivo and in vitro. To construct animal models, we utilized d-galactose (D-gal) injection to induce oxidative stress combined with a low calcium (the exact percentage in the diet was 0.1%) diet. Thirteen-week-old Kunming female mice were gavaged with water extract of FLL for 20 days. Then, eight-month-old Kunming female mice were treated with FLL under standard administration and diet as the aged group. In vitro, MC3T3-E1 cells stimulated by H2O2 were treated with FLL for 24 h. The micro-CT results showed that the modeling approach combining oxidative stress with a low calcium diet caused low conversion type osteoporosis in mice. FLL exerted a prominent effect on preventing osteoporosis by inhibiting oxidative stress, increasing bone mineral density (BMD), improving bone microstructure, and promoting osteoblast proliferation and osteoprotegerin (OPG) protein expression; however, FLL had no therapeutic effect on bone loss in aged mice. In conclusion, FLL showed outstanding anti-bone loss ability both in vivo and in vitro and could probably be developed as a prophylactic agent for osteoporosis.